Evidence map›Paper›PMID 24457412›Full record

ArticleChest2014

Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma.

Jie Zhu, Simon D Message, Yusheng Qiu, Patrick Mallia, Tatiana Kebadze, Marco Contoli, Christine K Ward, Elliot S Barnathan, Mary Ann Mascelli, Onn M Kon and 4 more

2 registry-linked trialsOpen access · hybridAbstract readControlled Clinical Trial
In one paragraph

Article in Chest, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03513458 phase1 / phase2withdrawnnot on this mapstarted 2020, after this paper: background citation

Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2020 to 2021Enrolled0ConditionsAsthmaArmsAnakinra, Anakinra Matching Placebo, Dermatophagoides Farinae
NCT03513471 phase1 / phase2withdrawnnot on this mapstarted 2019, after this paper: background citation

Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2021Enrolled0ConditionsAsthmaArmsAnakinra, Anakinra Matching Placebo, Dermatophagoides Farinae
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Controlled Human Infection Challenge Studies with RSV.Current topics in microbiology and immunology · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Jie ZhuDepartment of Respiratory Medicine; National Heart and Lung Institute, Imperial College London, London, England.
Simon D MessageDepartment of Respiratory Medicine; Imperial College Healthcare NHS Trust, London, England.
Yusheng QiuNational Heart and Lung Institute, Imperial College London, London, England.
Patrick MalliaDepartment of Respiratory Medicine; Imperial College Healthcare NHS Trust, London, England.
Tatiana KebadzeDepartment of Respiratory Medicine.
Marco ContoliDepartment of Respiratory Medicine; Imperial College Healthcare NHS Trust, London, England; Research Centre on Asthma and COPD, University of Ferrara, Ferrara, Italy.
Christine K WardCentocor Inc, Malvern, PA.
Elliot S BarnathanCentocor Inc, Malvern, PA.
Mary Ann MascelliCentocor Inc, Malvern, PA.
Onn M KonImperial College Healthcare NHS Trust, London, England.
Alberto PapiResearch Centre on Asthma and COPD, University of Ferrara, Ferrara, Italy.
Luminita A StanciuDepartment of Respiratory Medicine.
Peter K JefferyNational Heart and Lung Institute, Imperial College London, London, England.
Sebastian L JohnstonDepartment of Respiratory Medicine; Imperial College Healthcare NHS Trust, London, England. Electronic address: s.johnston@imperial.ac.uk.
Imperial College Healthcare NHS Trust · GBLung Institute · USUniversity of Ferrara · ITImperial College London · GB

Funding

European Research Council 233015Medical Research Council G1000758Wellcome Trust
6 · The paper itself

Abstract

backgroundThe nature of bronchial mucosal inflammation and its physiologic and clinical significance in rhinovirus-induced asthma exacerbations is unclear. We investigated bronchial mucosal inflammatory response and its association with physiologic and clinical outcomes in an experimental model of rhinovirus-induced asthma exacerbations.

methodsWe used immunohistochemistry methods to detect phenotypes of inflammatory cells infiltrating the bronchial mucosa before and after experimental rhinovirus infection in 10 subjects with asthma and 15 normal subjects.

resultsCompared with baseline, rhinovirus infection significantly increased the number of epithelial (P = .005) and subepithelial (P = .017) neutrophils in subjects with asthma only and subepithelial CD68+ macrophages in both subjects with asthma (P = .009) and normal subjects (P = .018) but more so in those with asthma (P = .021). Numbers of CD45+, CD68+, and CD20+ cells; neutrophils; and eosinophils at day 4 postinfection were positively associated with virus load (r = 0.50-0.72, P = .016-0.03). At acute infection in subjects with asthma, CD4+ cells correlated with chest symptom scores (r = 0.69, P = .029), the fall in the 10% fall in FEV1 (PC10) correlated with neutrophils (r = -0.89, P = .029), the PC10 correlated inversely with CD4+ (r = -0.67, P = .023) and CD8+ cells (r = -0.65, P = .03), the 20% fall in FEV1 was inversely associated with CD20+ cells (r = -0.65, P = .03), and higher epithelial CD8+ cell counts were significantly associated with a greater maximum fall in FEV1 (r = -0.72, P = .03), whereas higher subepithelial mast cell counts were significantly associated with a lower maximum percent fall in peak expiratory flow (r = 0.8, P = .024).

conclusionsIn subjects with asthma, rhinovirus infection induces bronchial mucosal neutrophilia and more severe monocyte/macrophage infiltration than in normal subjects. Airway neutrophils, eosinophils, and T and B lymphocytes during infection are related to virus load and physiologic and clinical severity, whereas mast cells are related to greater lung function.

Indexed as

RhinovirusAdultAsthmaCommon ColdComorbidityEosinophilsFemaleHumansLungLymphocytesMacrophages, AlveolarMaleMast CellsNeutrophilsPneumoniaSeverity of Illness Index

Identifiers

PMID24457412
PMCPMC4042510
OpenAlexW2105755794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.